These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 24564711)

  • 1. The proteomics of prostate cancer exosomes.
    Drake RR; Kislinger T
    Expert Rev Proteomics; 2014 Apr; 11(2):167-77. PubMed ID: 24564711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
    Principe S; Jones EE; Kim Y; Sinha A; Nyalwidhe JO; Brooks J; Semmes OJ; Troyer DA; Lance RS; Kislinger T; Drake RR
    Proteomics; 2013 May; 13(10-11):1667-1671. PubMed ID: 23533145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer.
    Duijvesz D; Burnum-Johnson KE; Gritsenko MA; Hoogland AM; Vredenbregt-van den Berg MS; Willemsen R; Luider T; Paša-Tolić L; Jenster G
    PLoS One; 2013; 8(12):e82589. PubMed ID: 24391718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.
    Barceló M; Castells M; Bassas L; Vigués F; Larriba S
    Sci Rep; 2019 Sep; 9(1):13772. PubMed ID: 31551516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-depth proteomic analyses of direct expressed prostatic secretions.
    Drake RR; Elschenbroich S; Lopez-Perez O; Kim Y; Ignatchenko V; Ignatchenko A; Nyalwidhe JO; Basu G; Wilkins CE; Gjurich B; Lance RS; Semmes OJ; Medin JA; Kislinger T
    J Proteome Res; 2010 May; 9(5):2109-16. PubMed ID: 20334419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate stromal cell proteomics analysis discriminates normal from tumour reactive stromal phenotypes.
    Webber JP; Spary LK; Mason MD; Tabi Z; Brewis IA; Clayton A
    Oncotarget; 2016 Apr; 7(15):20124-39. PubMed ID: 26934553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes as biomarker enriched microvesicles: characterization of exosomal proteins derived from a panel of prostate cell lines with distinct AR phenotypes.
    Hosseini-Beheshti E; Pham S; Adomat H; Li N; Tomlinson Guns ES
    Mol Cell Proteomics; 2012 Oct; 11(10):863-85. PubMed ID: 22723089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of prostate-enriched proteins by in-depth proteomic analyses of expressed prostatic secretions in urine.
    Principe S; Kim Y; Fontana S; Ignatchenko V; Nyalwidhe JO; Lance RS; Troyer DA; Alessandro R; Semmes OJ; Kislinger T; Drake RR; Medin JA
    J Proteome Res; 2012 Apr; 11(4):2386-96. PubMed ID: 22339264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosome proteomic analyses identify inflammatory phenotype and novel biomarkers in African American prostate cancer patients.
    Panigrahi GK; Praharaj PP; Kittaka H; Mridha AR; Black OM; Singh R; Mercer R; van Bokhoven A; Torkko KC; Agarwal C; Agarwal R; Abd Elmageed ZY; Yadav H; Mishra SK; Deep G
    Cancer Med; 2019 Mar; 8(3):1110-1123. PubMed ID: 30623593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal proteins as prostate cancer biomarkers in urine: From mass spectrometry discovery to immunoassay-based validation.
    Wang L; Skotland T; Berge V; Sandvig K; Llorente A
    Eur J Pharm Sci; 2017 Feb; 98():80-85. PubMed ID: 27664330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic Profiling of Serum-Derived Exosomes from Ethnically Diverse Prostate Cancer Patients.
    Turay D; Khan S; Diaz Osterman CJ; Curtis MP; Khaira B; Neidigh JW; Mirshahidi S; Casiano CA; Wall NR
    Cancer Invest; 2016; 34(1):1-11. PubMed ID: 26536157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel.
    Kharaziha P; Chioureas D; Rutishauser D; Baltatzis G; Lennartsson L; Fonseca P; Azimi A; Hultenby K; Zubarev R; Ullén A; Yachnin J; Nilsson S; Panaretakis T
    Oncotarget; 2015 Aug; 6(25):21740-54. PubMed ID: 25844599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced disease.
    Neuhaus J; Schiffer E; von Wilcke P; Bauer HW; Leung H; Siwy J; Ulrici W; Paasch U; Horn LC; Stolzenburg JU
    PLoS One; 2013; 8(6):e67514. PubMed ID: 23826311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Database-augmented Mass Spectrometry Analysis of Exosomes Identifies Claudin 3 as a Putative Prostate Cancer Biomarker.
    Worst TS; von Hardenberg J; Gross JC; Erben P; Schnölzer M; Hausser I; Bugert P; Michel MS; Boutros M
    Mol Cell Proteomics; 2017 Jun; 16(6):998-1008. PubMed ID: 28396511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Extracellular Vesicle Isolation Methods on Downstream Mirna Analysis in Semen: A Comparative Study.
    Mercadal M; Herrero C; López-Rodrigo O; Castells M; de la Fuente A; Vigués F; Bassas L; Larriba S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32824915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-omics Biomarker Pipeline Reveals Elevated Levels of Protein-glutamine Gamma-glutamyltransferase 4 in Seminal Plasma of Prostate Cancer Patients.
    Drabovich AP; Saraon P; Drabovich M; Karakosta TD; Dimitromanolakis A; Hyndman ME; Jarvi K; Diamandis EP
    Mol Cell Proteomics; 2019 Sep; 18(9):1807-1823. PubMed ID: 31249104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules.
    Ramteke A; Ting H; Agarwal C; Mateen S; Somasagara R; Hussain A; Graner M; Frederick B; Agarwal R; Deep G
    Mol Carcinog; 2015 Jul; 54(7):554-65. PubMed ID: 24347249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary exosomal proteins as (pan-)cancer biomarkers: insights from the proteome.
    Erozenci LA; Böttger F; Bijnsdorp IV; Jimenez CR
    FEBS Lett; 2019 Jul; 593(13):1580-1597. PubMed ID: 31198995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes as A Next-Generation Diagnostic and Therapeutic Tool in Prostate Cancer.
    Gaglani S; Gonzalez-Kozlova E; Lundon DJ; Tewari AK; Dogra N; Kyprianou N
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes.
    Salciccia S; Capriotti AL; Laganà A; Fais S; Logozzi M; De Berardinis E; Busetto GM; Di Pierro GB; Ricciuti GP; Del Giudice F; Sciarra A; Carroll PR; Cooperberg MR; Sciarra B; Maggi M
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.